根据一份提交给美国证券交易委员会的文件,B&I Contractors已于2026年6月26日,向法院提交了针对HCW Biologics Inc.的“有偏见自愿撤诉”申请。此举意味着该法律诉讼程序被正式终止,且原告未来不得基于相同事由再次提起诉讼。
根据一份提交给美国证券交易委员会的文件,B&I Contractors已于2026年6月26日,向法院提交了针对HCW Biologics Inc.的“有偏见自愿撤诉”申请。此举意味着该法律诉讼程序被正式终止,且原告未来不得基于相同事由再次提起诉讼。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.